Glycosaminoglycans

Test Code
30422


CPT Codes
83864

Preferred Specimen
20 mL (pediatric: 4 mL) first void clean catch urine in a sterile screw cap container


Minimum Volume
10 mL (pediatric 2 mL)


Other Acceptable Specimens
Random urine


Instructions
An early morning specimen is preferred. Freeze immediately.
Include the patient age with the requisition.


Transport Temperature
Frozen


Specimen Stability
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 8 weeks


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Unfrozen specimens • Specimens outside of listed stability


Methodology
Colorimetric (1,9-Dimethyl-Methylene Blue) Dye Binding

FDA Status
The performance characteristics of the listed assay was validated by BioAgilytix Diagnostics. The US FDA has not approved or cleared this test. The results of this assay can be used for clinical diagnosis without FDA approval. BioAgilytix Diagnostics is a CLIA certified, CAP accredited laboratory for performing high complexity assays such as this one.

Setup Schedule
Set up: Varies; Report available: up to 7 business days


Clinical Significance
The mucopolysaccharidoses (MPSs) are a family of inheritable disorders caused by deficiency of lysomal enzymes required to degrade mucopolysaccharides, also known as glycosaminoglycans (GAGs). The undegraded or partially degraded gags are stored in lysosomes and excreted in the urine. The quantity of excreted urinary gags is age-dependent. Infants secrete more GAGs than adults. Normal urine contains primarily chondroitin sulfate with small quantities of heparin sulfate and dermatan sulfate.
Once mucopolysaccharidoses is diagnosed by total GAG analysis, a differential diagnosis based upon the abnormal distribution of sulfated GAGs in urine must be performed. Differential diagnosis is a requirement because many of the various enzyme deficiencies share similar clincal features. These features include a chronic and progressive course, multi-system involvement and organomegaly. Hearing, vision, cardiovascular function and joint mobility are affected. Profound mental retardation is found in the Hurler, Hunter and San Filippo syndromes (MPS types I, II and III), but normal intellectual functioning is retained in other MPSs and some mildly affected Hunter patients.




The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.